Citations

Showing 10 of 108083 citations.

MAC Plus Study: A Retrospective Study Correlating DNA Variants, Clinical Course and Outcomes from 187 Patients Who Underwent Testing Using an Atypical Hemolytic Uremic Syndrome and Thrombotic Microangiopathy Genetic Sequencing Panel
Kain, Jamey , Erickson, Stephen B., Singh, Prince Kumar , Langman, Craig B. , Hanna, Ramy, Brakeman, Paul, Dvorak, Christopher C. , Lawicki, Shaun , Sharma, Amita , Lim, Jooeun, Venkataramani, Sujatha, Ero, Mike, Lewis, Bradley, Dvorak, Christopher C , Moon, Ji Hyun , Kain, Jamey, Fervenza, Fernando C. , Singh, Prince, Tehranian, Shahrzad , Lewis, Bradley

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2776-2777

10.1182/blood-2022-162838 Get It

FLIPI-3: A New PET-Based Prognostic Index for Follicular Lymphoma Based on Results from a Validation Study with the ECOG-ACRIN E2408 Cohort
St‐Pierre, Frédérique , Kocherginsky, Masha , Quon, Andrew , Baratto, Lucia , Kostakoğlu, Lale , Evens, Andrew M. , Evens, Andrew M , Broski, Stephen M. , Sun, Zequn , Savas, Hatice , Winter, Jane N. , Witzig, Thomas E. , Kahl, Brad S. , Gordon, Leo I.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6480-6481

10.1182/blood-2022-162114 Get It

Efficacy and Safety of Nemtabrutinib, a Wild-Type and C481S-Mutated Bruton Tyrosine Kinase Inhibitor for B-Cell Malignancies: Updated Analysis of the Open-Label Phase 1/2 Dose-Expansion Bellwave-001 Study
Woyach, Jennifer A. , Eradat, Herbert, Brander, Danielle M. , Tees, Michael, Ghori, Razi , Reddy, Nishitha , Farooqui, Mohammed Z.H. , Byrd, John C. , Byrd, John C , Flinn, Ian W. , Awan, Farrukh T. , Parikh, Sameer A. , Phillips, Tycel , Stephens, Deborah M.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7004-7006

10.1182/blood-2022-163596 Get It

A Multicenter Phase I Dose-Escalation Trial of a Novel Glutaminase Inhibitor Telaglenastat in Combination with Carfilzomib and Dexamethasone in Relapsed and Refractory Multiple Myeloma
Allred, Jacob B., Kumar, Shaji , Costello, Brian A. , Gonsalves, Wilson I. , Neparidze, Natalia , Reid, Joel M. , Shapiro, Geoffrey I. , Piekarz, Richard , Baz, Rachid , Devarakonda, Srinivas

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7315-7316

10.1182/blood-2022-164966 Get It

Five-Year Results and Overall Survival Update from the Phase 3 Randomized Study Augment: Lenalidomide Plus Rituximab (R2) Vs Rituximab Plus Placebo in Patients with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma
Leonard, John P. , Offner, Fritz , Mayer, Jiří , Zhang, Huilai , Nowakowski, Grzegorz S. , Gkasiamis, Argyrios, Mikita-Geoffroy, Joanna, Rowe, Everton, Trněný, Marek , Scheinberg, Phillip , Gkasiamis, Argyrios, Gribben, John G.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 561-563

10.1182/blood-2022-158631 Get It

Early and Sustained Undetectable Measurable Residual Disease (MRD) after Idecabtagene Vicleucel (ide-cel) Defines a Subset of Multiple Myeloma (MM) Patients in Karmma Achieving Prolonged Survival
Manrique, Irene , Campbell, Timothy , Kazanecki, Christian C. , Martin, Nathan , Kaiser, Shari M. , Anderson, Larry D. , Lin, Yi , Munshi, Nikhil C. , Anderson, Larry D , Paiva, Bruno , Rytlewski, Julie , Berdeja, Jesús G. , Lonial, Sagar , Raje, Noopur , Moreau, Philippe , Miguel, Jesús F. San

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2104-2105

10.1182/blood-2022-166658 Get It

Outcomes of Axicabtagene Ciloleucel in Comparison with Chemoimmunotherapy (CIT) in an Elderly Population for Treatment of Relapsed or Refractory (r/r) Large B-Cell Lymphoma (LBCL) after Two or More Lines of Prior Therapy
Lunning, Matthew A. , Wang, Hailin , Hu, Zhen‐Huan , Jacobson, Caron A. , Lin, Yi , Hill, Brian T. , Neelapu, Sattva S. , Miao, Harry , Shahani, Shilpa, Patel, Anik R. , Spooner, Clare, Fu, Christine, Xu, Hairong, Pasquini, Marcelo C. , Locke, Frederick L. , Siddiqi, Tanya , Ahmed, Sairah , Miklos, David B. , Ghobadi, Armin , Westin, Jason R.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1852-1855

10.1182/blood-2022-162421 Get It

Loss of Nr4a1 Causes an Elevated Expression of Co-Inhibitory Receptor:Ligand Axes and Results in a Diminished T Cell-Mediated Lymphoma Cell Killing in Aggressive Lymphoma
Fechter, Karoline , Wenzl, Kerstin , Szmyra, Marta , Haingartner, Sandra, Novak, Anne J. , Greinix, Hildegard, Beham‐Schmid, Christine, Neumeister, Peter , Pansy, Katrin , Arra, Aditya , Novak, Joseph P. , Ramsay, Alan G. , Deutsch, Alexander

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2038-2039

10.1182/blood-2022-163034 Get It